Author details

Full Name

Christel Herold-Mende

Affiliation

ORCID

Career Start Year

1993

Papers

344

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37162029	Repurposing FDA-Approved Drugs for Temozolomide-Resistant IDH1 Mutant Glioma Using High-Throughput Miniaturized Screening on Droplet Microarray Chip.		2023
36239995	A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.	Clin Cancer Res	2023
36282277	Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.	Clinical Cancer Research	2023
35977048	BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.	Neuro Oncol	2023
37936247	EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.		2023
37653401	scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis.	BMC Bioinformatics	2023
37883975	Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas.	Cell Rep Med	2023
37776353	Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.	Acta Neuropathol	2023
37682326	Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580.		2023
36765922	MR Intensity Normalization Methods Impact Sequence Specific Radiomics Prognostic Model Performance in Primary and Recurrent High-Grade Glioma.		2023
37190109	The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells.		2023
37058257	DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.	Clin Cancer Res	2023
36798537	Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.	Int J Tryptophan Res	2023
37244463	Triphenylphosphonium-functionalized N-heterocyclic carbene platinum complexes [(NHC-TPP)Pt] induce cell death of human glioblastoma cancer stem cells.		2023
36933012	Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.	Acta Neuropathol	2023
37432629	Preclinical Models of Meningioma.		2023
37173969	Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical Score.		2023
37296499	Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.	Neuropathol Appl Neurobiol	2023
36672428	Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression.	Cancers (Basel)	2023
36980707	MR-Class: A Python Tool for Brain MR Image Classification Utilizing One-vs-All DCNNs to Deal with the Open-Set Recognition Problem.		2023
35053502	STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death.	Cancers	2022
35511748	HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.	Neuro Oncol	2022
36353533	Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model.	Front Oncol	2022
36291841	Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells.	Cancers	2022
35954492	Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma.	Cancers	2022
35575826	[Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients].	HNO	2022
36087816	An N-heterocyclic carbene iridium(III) complex as a potent anti-cancer stem cell therapeutic.		2022
35551407	Diagnostic potential of extracellular vesicles in meningioma patients.	Neuro Oncol	2022
36203443	The impact of tumor metabolic activity assessed by F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients.	Frontiers in Oncology	2022
35616165	Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.	Chemistry - A European Journal	2022
36326151	Boron- and phosphorus-containing molecular/nano platforms: exploiting pathological redox imbalance to fight cancer.	Nanoscale	2022
35357562	Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study.	Acta Neuropathol	2022
35984495	Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas.	Acta Neuropathol	2022
36115843	PFKFB4 interacts with FBXO28 to promote HIF-1Î± signaling in glioblastoma.	Oncogenesis	2022
35977725	Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.	Neuropathol Appl Neurobiol	2022
35660939	DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.	Acta Neuropathol	2022
36497175	CHRDL1 Regulates Stemness in Glioma Stem-like Cells.		2022
36662064	Evaluation of the Cytotoxicity of Cationic Polymers on Glioblastoma Cancer Stem Cells.		2022
34232320	A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma.	Neuro Oncol	2022
35293640	Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.	Chemistry - A European Journal	2022
34967922	Oligosarcomas, IDH-mutant are distinct and aggressive.	Acta Neuropathol	2022
35158950	Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy.	Cancers (Basel)	2022
35012690	Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.	Acta Neuropathol Commun	2022
34706068	High-Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance.	International Journal of Cancer	2022
34534627	Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells.	Int J Radiat Oncol Biol Phys	2022
34885009	Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.	Cancers	2021
33809510	Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines.	Cancers	2021
33807125	Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients.	Cancers	2021
33803955	Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.	International Journal of Molecular Sciences	2021
33540592	An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment.	Cancers	2021